Generative AI in clinical trials market worldwide 2022-2032
According to some estimates, the generative artificial intelligence (Generative AI) market for clinical trials worldwide will exceed one billion U.S. dollars by 2032. Compared to 140 million dollars in 2022, that would be a compound annual growth rate of nearly 24 percent. Generative AI in clinical trials includes: clinical trial design, outcome prediction, adverse event detection, data imputation and denoising, data generation, and other applications. Compared to traditional AI, generative AI is considered the next generation of AI which is much more creative and can actually generate something new.
